Advanced/ Metastatic Her-2 Positive Breast Cancer
1 clinical trials · Condition
◉ Watch Advanced/ Metastatic Her-2 Positive Breast Cancer
| Record | Firm | Date |
|---|---|---|
| GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer (NCT05575804) | Fudan University | 2022-10-01 |
Track Advanced/ Metastatic Her-2 Positive Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.